(Q33869341)

29 July 2017

1 reference

title

Physical and chemical properties of radionuclide therapy (English)

1 reference

29 July 2017

Wessels BW

1

1 reference

29 July 2017

Meares CF

series ordinal

2

1 reference

29 July 2017

publication date

1 April 2000

1 reference

Seminars in Radiation Oncology

29 July 2017

published in

1 reference

29 July 2017

volume

10

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

115-122

1 reference

Treatment planning optimization for linear accelerator radiosurgery.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980048-X

7 January 2021

Radionuclide selection and model absorbed dose calculations for radiolabeled tumor associated antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980048-X

7 January 2021

Radiation absorbed dose estimates at the cellular level for some electron-emitting radionuclides for radioimmunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980048-X

7 January 2021

Targeting medullary thyroid carcinomas with bispecific antibodies and bivalent haptens. Results and clinical perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980048-X

7 January 2021

Antibodies against metal chelates

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980048-X

7 January 2021

Kinetics of the dissociation of indium-(p-substituted-benzyl)ethylenediaminetetraacetic acid hapten analogues from the monoclonal anti-hapten antibody CHA255.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980048-X

7 January 2021

Biodistribution in tumour-bearing mice of two 90Y-labelled biotins using three-step tumour targeting

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980048-X

7 January 2021

Chelating agents for the binding of metal ions to macromolecules

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980048-X

7 January 2021

A new route to “bifunctional” chelating agents: Conversion of amino acids to analogs of ethylenedinitrilotetraacetic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980048-X

7 January 2021

Copper chelates as probes of biological systems: stable copper complexes with a macrocyclic bifunctional chelating agent.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980048-X

7 January 2021

The peptide way to macrocyclic bifunctional chelating agents: synthesis of 2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecane-N,N',N",N'''-tetraacetic acid and study of its yttrium(III) complex

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980048-X

7 January 2021

Synthesis, metal chelate stability studies, and enzyme digestion of a peptide-linked DOTA derivative and its corresponding radiolabeled immunoconjugates

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980048-X

7 January 2021

Tissue-level transport mechanisms of intraperitoneally-administered monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980048-X

7 January 2021

Exploiting altered glycosylation patterns in cancer: progress and challenges in diagnosis and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980048-X

7 January 2021

Lymphoma-selective antibody Lym-1 recognizes a discontinuous epitope on the light chain of HLA-DR10.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980048-X

7 January 2021

Selection of radionuclides for radioimmunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980048-X

7 January 2021

Tolerance of the liver to the effects of Yttrium-90 radiation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980048-X

7 January 2021

Proliferation and the advantage of longer-lived radionuclides in radioimmunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980048-X

7 January 2021

Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980048-X

7 January 2021

Quantitative imaging of I-124 using positron emission tomography with applications to radioimmunodiagnosis and radioimmunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980048-X

7 January 2021

An overview of imaging techniques and physical aspects of treatment planning in radioimmunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980048-X

7 January 2021

10.1016/S1053-4296(00)80048-X

Identifiers

DOI

1 reference

29 July 2017

1 reference